Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review

January 2019 | 40 pages | ID: S7FC5C485B0EN
GlobalData

Abstracts

Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio includes radiological products including an array of x-ray imaging agents and the MRT imaging agent; and veterinary pharmaceuticals. It also offers synthesis of active pharmaceutical substances (APIs), drug formulation and pharmaceutical production and contract research. Apart from Austria, Sanochemia offers its products in Rest of Europe, Asia, MENA (Middle East and North Africa), Commonwealth of Independent States (CIS) countries and rest of the world. The company has sales offices in Switzerland, Germany, the UK and the US. Sanochemia is headquartered in Vienna, Austria.

Sanochemia Pharmazeutika AG Key Recent Developments

May 24,2018: SANOCHEMIA: Strong EBIT improvement

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Sanochemia Pharmazeutika AG - Key Facts
Sanochemia Pharmazeutika AG - Key Employees
Sanochemia Pharmazeutika AG - Key Employee Biographies
Sanochemia Pharmazeutika AG - Major Products and Services
Sanochemia Pharmazeutika AG - History
Sanochemia Pharmazeutika AG - Company Statement
Sanochemia Pharmazeutika AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Sanochemia Pharmazeutika AG - Business Description
Business Segment: Human Pharmaceutical
Overview
Performance
Business Segment: Production
Overview
Performance
Business Segment: Research and Development (R&D)
Overview
Performance
Business Segment: Veterinary Pharmaceuticals
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Austria
Performance
Geographical Segment: Belgium
Performance
Geographical Segment: Commonwealth of Independent States
Performance
Geographical Segment: Germany
Performance
Geographical Segment: MENA
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: Rest of the World
Performance
Sanochemia Pharmazeutika AG - Corporate Strategy
Sanochemia Pharmazeutika AG - SWOT Analysis
SWOT Analysis - Overview
Sanochemia Pharmazeutika AG - Strengths
Sanochemia Pharmazeutika AG - Weaknesses
Sanochemia Pharmazeutika AG - Opportunities
Sanochemia Pharmazeutika AG - Threats
Sanochemia Pharmazeutika AG - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Sanochemia Pharmazeutika AG, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 24, 2018: SANOCHEMIA: Strong EBIT improvement

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Sanochemia Pharmazeutika AG, Key Facts
Sanochemia Pharmazeutika AG, Key Employees
Sanochemia Pharmazeutika AG, Key Employee Biographies
Sanochemia Pharmazeutika AG, Major Products and Services
Sanochemia Pharmazeutika AG, History
Sanochemia Pharmazeutika AG, Other Locations
Sanochemia Pharmazeutika AG, Subsidiaries
Sanochemia Pharmazeutika AG, Key Competitors
Sanochemia Pharmazeutika AG, Ratios based on current share price
Sanochemia Pharmazeutika AG, Annual Ratios
Sanochemia Pharmazeutika AG, Annual Ratios (Cont.1)
Sanochemia Pharmazeutika AG, Annual Ratios (Cont.2)
Sanochemia Pharmazeutika AG, Interim Ratios
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Sanochemia Pharmazeutika AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Sanochemia Pharmazeutika AG, Performance Chart (2013 - 2017)
Sanochemia Pharmazeutika AG, Ratio Charts
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Probiodrug AG
Orexo AB
Lantheus Medical Imaging Inc
Amynon Biotech Gmbh
AMAG Pharmaceuticals Inc
Alpex Pharma SA
Alliance Pharma Plc
Advanced Targeting Systems